Eli Lilly’s Verzenio snags first-in-class FDA approval for early breast cancer. But limited label poses a challenge

Eli Lilly’s Verzenio snags first-in-class FDA approval for early breast cancer. But limited label poses a challenge
aliu
Wed, 10/13/2021 – 05:56